174 related articles for article (PubMed ID: 8675647)
1. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.
Chen L; Chen D; Manome Y; Dong Y; Fine HA; Kufe DW
J Clin Invest; 1995 Dec; 96(6):2775-82. PubMed ID: 8675647
[TBL] [Abstract][Full Text] [Related]
2. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
Tai YT; Strobel T; Kufe D; Cannistra SA
Cancer Res; 1999 May; 59(9):2121-6. PubMed ID: 10232598
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
Kurihara T; Brough DE; Kovesdi I; Kufe DW
J Clin Invest; 2000 Sep; 106(6):763-71. PubMed ID: 10995787
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus vector-based purging of multiple myeloma cells.
Teoh G; Chen L; Urashima M; Tai YT; Celi LA; Chen D; Chauhan D; Ogata A; Finberg RW; Webb IJ; Kufe DW; Anderson KC
Blood; 1998 Dec; 92(12):4591-601. PubMed ID: 9845525
[TBL] [Abstract][Full Text] [Related]
5. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir.
Manome Y; Abe M; Hagen MF; Fine HA; Kufe DW
Cancer Res; 1994 Oct; 54(20):5408-13. PubMed ID: 7923173
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen.
Kasuya H; Pawlik TM; Mullen JT; Donahue JM; Nakamura H; Chandrasekhar S; Kawasaki H; Choi E; Tanabe KK
Cancer Res; 2004 Apr; 64(7):2561-7. PubMed ID: 15059912
[TBL] [Abstract][Full Text] [Related]
7. Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.
Gupta VK; Park JO; Kurihara T; Koons A; Mauceri HJ; Jaskowiak NT; Kufe DW; Weichselbaum RR; Posner MC
Gene Ther; 2003 Feb; 10(3):206-12. PubMed ID: 12571627
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
Yu B; Zhang Y; Zhan Y; Zha X; Wu Y; Zhang X; Dong Q; Kong W; Yu X
Oncol Rep; 2011 Jul; 26(1):255-64. PubMed ID: 21573500
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes.
Sugaya S; Fujita K; Kikuchi A; Ueda H; Takakuwa K; Kodama S; Tanaka K
Hum Gene Ther; 1996 Jan; 7(2):223-30. PubMed ID: 8788173
[TBL] [Abstract][Full Text] [Related]
11. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer.
Yee D; McGuire SE; BrĂ¼nner N; Kozelsky TW; Allred DC; Chen SH; Woo SL
Hum Gene Ther; 1996 Jun; 7(10):1251-7. PubMed ID: 8793549
[TBL] [Abstract][Full Text] [Related]
13. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
[TBL] [Abstract][Full Text] [Related]
14. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene.
Aoki K; Yoshida T; Matsumoto N; Ide H; Hosokawa K; Sugimura T; Terada M
Hum Gene Ther; 1997 Jun; 8(9):1105-13. PubMed ID: 9189768
[TBL] [Abstract][Full Text] [Related]
16. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
Wildner O; Morris JC
J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated targeted expression of toxic genes to adrenocorticotropin-producing pituitary tumors using the proopiomelanocortin promoter.
Lee EJ; Martinson F; Kotlar T; Thimmapaya B; Jameson JL
J Clin Endocrinol Metab; 2001 Jul; 86(7):3400-9. PubMed ID: 11443217
[TBL] [Abstract][Full Text] [Related]
18. A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
Maeda T; O-Wang J; Matsubara H; Asano T; Ochiai T; Sakiyama S; Tagawa M
Cancer Gene Ther; 2001 Nov; 8(11):890-6. PubMed ID: 11773979
[TBL] [Abstract][Full Text] [Related]
19. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
20. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]